We are live on ! Find out more
CCM

Consonance Capital Management Portfolio holdings

AUM $7.28M
1-Year Est. Return 43.59%
This Fund
S&P 500
This Quarter Est. Return
+24.81%
1 Year Est. Return
-43.59%
3 Year Est. Return
+313.86%
5 Year Est. Return
+886.32%
10 Year Est. Return
–
AUM
$672M
AUM Growth
+$62.1M
Cap. Flow
+$17.3M
Cap. Flow %
2.57%
Top 10 Hldgs %
63.33%
Holding
37
New
10
Increased
13
Reduced
3
Closed
10

Top Buys

Rank Stock Value
1
MYGN icon
Myriad Genetics
MYGN
+$54M
2
MASI
Masimo
MASI
+$27.2M
3
INFI
Infinity Pharmaceuticals, Inc.
INFI
+$16.9M
4
OSIR
Osiris Therapeutics, Inc. Common Stock
OSIR
+$16.9M
5
VNDA icon
Vanda Pharmaceuticals
VNDA
+$16M

Top Sells

Rank Stock Value
1
ENDP
Endo International plc
ENDP
+$45.3M
2
CSII
Cardiovascular Systems, Inc.
CSII
+$37.5M
3
WX
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
+$30.1M
4
MDCO
Medicines Co
MDCO
+$25.5M
5
EBS icon
Emergent Biosolutions
EBS
+$25.1M

Sector Composition

Rank Sector Weight
1 Healthcare 80.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AKRX
26
DELISTED
Akorn Inc
AKRX
$6.49M 0.97%
+295,000
New +$6.89M
LPDX
27
DELISTED
LIPOSCIENCE INC COM
LPDX
$1.41M 0.21%
443,052
– –
EBS icon
28
Emergent Biosolutions
EBS
$373M
– –
-1,093,828
Closed -$25.1M
CSII
29
DELISTED
Cardiovascular Systems, Inc.
CSII
– –
-1,093,234
Closed -$37.5M
ENDP
30
DELISTED
Endo International plc
ENDP
– –
-670,900
Closed -$45.3M
AMAG
31
DELISTED
AMAG Pharmaceuticals
AMAG
– –
-1,034,537
Closed -$25.1M
MDCO
32
DELISTED
Medicines Co
MDCO
– –
-661,355
Closed -$25.5M
SCMP
33
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
– –
-925,214
Closed -$8.7M
ARIA
34
DELISTED
Ariad Pharmaceuticals Inc
ARIA
– –
-12,260
Closed -$84K
SLXP
35
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
– –
-257,779
Closed -$23.2M
CHDX
36
DELISTED
CHINDEX INTL INC
CHDX
– –
-363,429
Closed -$6.33M
CADX
37
DELISTED
CADENCE PHARMACEUTICALS, INC COM STK
CADX
– –
-2,608,180
Closed -$23.6M
1
2

Similar funds

GPC
Garrison Point Capital Walnut Creek, California $6.82M AUM 21.38% 1-Year Est. Return
BPM
Bronson Point Management Fairfield, Connecticut $8.26M AUM 46.43% 1-Year Est. Return
TVPI
True Venture Partners IV Palo Alto, California $8.41M AUM 78.89% 1-Year Est. Return
DCI
Data Collective II Palo Alto, California $8.44M AUM 11.7% 1-Year Est. Return
TPMI
Tilden Park Management I New York $5.38M AUM 28.49% 1-Year Est. Return
TP
Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return
SCG
Siris Capital Group New York $9.42M AUM 42.79% 1-Year Est. Return
CVGI
Craft Ventures GP I San Francisco, California $9.51M AUM 95.77% 1-Year Est. Return

Consonance Capital Management's Q1 2014 Portfolio in Review

As of Q1 2014, Consonance Capital Management held 37 positions worth $672M, up 10% from $610M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Consonance Capital Management's Q1 2014 filing shows 10 new, 13 increased, 3 reduced and 10 closed positions. Its largest new stake was Myriad Genetics: 1,744,150 shares worth $59.6M. The largest sale was Endo International plc, an estimated $45.3M.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, up from 62% a quarter earlier.

  • Consonance Capital Management's largest Q1 2014 buy was Myriad Genetics: 1,744,150 shares worth $59.6M.
  • Consonance Capital Management added most to Masimo in Q1 2014, an estimated $27.2M increase.
  • Consonance Capital Management's biggest Q1 2014 reduction was WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS, cutting an estimated $30.1M.
  • Consonance Capital Management fully exited Endo International plc in Q1 2014, selling an estimated $45.3M.
  • Consonance Capital Management's ten largest holdings make up 63% of its $672M portfolio in Q1 2014.
  • Consonance Capital Management opened 10 new positions and closed 10 in Q1 2014.
  • Consonance Capital Management's portfolio value rose 10% quarter-over-quarter to $672M.

Based on Consonance Capital Management's 13F filing for Q1 2014, filed 15 May 2014.